Skip to main content

Advertisement

Log in

OnabotulinumtoxinA in chronic migraine: long-term efficacy in a prophylactic medication free cohort

  • MANAGEMENT AND THERAPY
  • Published:
Neurological Sciences Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Dodick DW, Turkel CC, RE DG, Aurora SK, Silberstein SD, Lipton RB, Diener HC, Brin MF, PREEMPT Chronic Migraine Study Group (2010) Onabotulinumtoxin A for treatment of chronic migraine: pooled results from the double-blind, randomized, placebo-controlled phases of the PREEMPT clinical program. Headache 50(6):921–936

    Article  Google Scholar 

  2. Blumenfeld AM, Stark RJ, Freeman MC, Orejudos A, Adams AM (2018) Long-term study of the efficacy and safety of Onabotulinumtoxin A for the prevention of chronic migraine: COMPEL study. J Headache Pain 19:13

    Article  Google Scholar 

  3. Headache Classification Committee of International Headache Society (2013) Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Cephalalgia 33:629–808

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Francesca Schiano di Cola.

Ethics declarations

All procedures were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments. Informed consent was obtained from all individual participants included in the study.

Conflict of interest

The authors declare that they have no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Schiano di Cola, F., Pari, E., Caratozzolo, S. et al. OnabotulinumtoxinA in chronic migraine: long-term efficacy in a prophylactic medication free cohort. Neurol Sci 39 (Suppl 1), 159–160 (2018). https://doi.org/10.1007/s10072-018-3391-5

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10072-018-3391-5

Navigation